Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
What you need to know about thyroid cancer screening
November 21, 2022

What is Thyroid Cancer? The thyroid is a gland in the front of the neck responsible for hormone production. When cells of the thyroid become abnormal, cancer develops. There are no screening tests to evaluate thyroid cancer cells' presence. A diagnosis is typically made when someone is being evaluated for…

Julie Scott, DNP

author

Articles
Early detection of pancreatic cancer through screening
November 21, 2022

What is Pancreatic Cancer? The pancreas is a gland in the abdomen that secretes pancreatic enzymes that help digestion. In addition, the pancreas also produces insulin, which helps control blood sugar levels in the body. When pancreas cells become abnormal, they grow irregularly and out of control. This abnormal cell…

Julie Scott, DNP

author

Articles
The Little-known Cancer – Cancer of Unknown Primary (CUP)
November 4, 2022

CUP, also known as Cancer of unknown primary, is Cancer that has metastasized from another body part. The site where it began, also called the primary site, is unknown in this case. Why CUP is a challenging cancer? Cancer of unknown primary is often challenging because it tends to be…

Vino Cherian

administrator

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice